Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × tremelimumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 10 Carcinoma, Non-Small-Cell Lung 5 Liver Neoplasms 4 Small Cell Lung Carcinoma 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Seminoma 1 Pancreatic Neoplasms 1 Nonseminomatous germ cell tumor 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms, Germ Cell and Embryonal 1 Metastatic Malignant Female Reproductive System Neoplasm 1 Mesothelioma 1 Lung Cancer Metastatic 1 Liver Cirrhosis 1 Hydronephrosis 1 Germinoma 1 Fallopian Tube Neoplasms 1 Dysgerminoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Adenocarcinoma, Follicular 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 50 Paclitaxel 14 Carboplatin 13 Cisplatin 12 lenvatinib 10 Pemetrexed 7 Saline Solution 5 Gemcitabine 5 Capecitabine 5 Albumin-Bound Paclitaxel 5 Oxaliplatin 4 Fluorouracil 4 Docetaxel 4 Bevacizumab 4 130-nm albumin-bound paclitaxel 4 patritumab deruxtecan 3 Leucovorin 3 olaparib 2 liposomal doxorubicin 2 enfortumab vedotin 2 Irinotecan 2 Histamine H2 Antagonists 2 Histamine Antagonists 2 Glucose 2 Dexamethasone 2 Cetuximab 2 Acetaminophen 2 zanidatamab 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡